HomeNews UpdatesMarketsandMarkets Highlighted by Investor’s Business Daily for Insights on Cancer Immunotherapy Market

Investor's Business Daily | November 13, 2017
MarketsandMarkets Highlighted by Investor’s Business Daily for Insights on Cancer Immunotherapy Market

Investor’s Business Daily recently quoted MarketsandMarkets, citing the market trends in cancer immunotherapy market.

Rising incidences of cancer across the globe has led to the healthcare providers focusing more on enhancing the quality of treatments such as immunotherapy, which is more effective and efficient as compared to the traditional chemotherapies. The global market for cancer immunotherapy is predicted to be worth $119.39 Billion by 2021, registering a high CAGR of 14.0% during the forecast period from 2016 to 2021.

For More Details:

https://www.investors.com/newsfeed/thomson-reuters-one/713484227-biocartis-group-nv-biocartis-announces-h1-2017-results/

Report mentioned in the above news is,

Cancer Immunotherapy Market by Type (Monoclonal Antibodies, Cancer Vaccines, Check Point Inhibitors & Immunomodulators), Application (Lung, Breast, Colorectal, Melanoma, Prostate, Head & Neck), End User (Hospital and Clinics) - Global Forecast to 2021

Press Release:

http://www.marketsandmarkets.com/PressReleases/cancer-immunotherapy.asp

Share this story

How can we help you?

To discuss how our team can help you and your business achieve true results,
Get in touch with us

  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved